Cholecystokinin (CCK) is a gastrointestinal hormone produced by discrete endocrine cells in the upper small intestine and released after ingestion of a meal. The present study was designed to determine if enhanced CCK secretion is associated with increases in intestinal CCK mRNA levels. Rats, prepared with indwelling intraduodenal cannulae, were first fed an elemental diet that did not stimulate CCK release. Next, as a means of stimulating CCK secretion, soybean trypsin inhibitor was perfused for up to 24 h. Trypsin inhibitor administration increased plasma CCK levels from 0.9±0.1 to -5 pmol/liter. RNA was prepared from the proximal small intestine at various times after trypsin inhibitor perfusion and mRNA levels analyzed by hybridization with a CCK cDNA probe. After 12 and 24 h of trypsin inhibitor treatment there were three-and fourfold increases, respectively, in CCK mRNA levels. In comparison, there was no change in l-actin mRNA levels. To determine if regulation of CCK mRNA was at the level of CCK gene transcription, labeled transcripts from nuclear run-on incubations were hybridized to immobilized CCK cDNA. In trypsin inhibitor-treated rats, a two-to threefold increase in transcriptional activity was observed, whereas jl-actin gene transcription levels were unaltered. These studies indicate that stimulation of CCK secretion is associated with an increase in intestinal CCK mRNA content resulting from an increase in CCK gene transcription.
Introduction
Cholecystokinin (CCK) is a classical gastrointestinal polypeptide hormone that was first identified in intestinal extracts by its ability to stimulate gallbladder contraction (1) . It has since been recognized that CCK is also a major regulator ofexocrine pancreatic secretion and gastric emptying, and has important effects on intestinal motility and perhaps satiety (2, 3) . Multiple molecular forms of CCK, ranging in size from the tetrapeptide CCK-4 to forms as large as CCK-58, have been identified in the intestine, brain, and plasma (4) (5) (6) (7) (8) . As a typical gut hormone, CCK is secreted into the circulation after the ingestion ofnutrients. With the development ofimproved assays for CCK, it has recently become possible to define many of the factors that regulate CCK secretion (9, 10) . In the rat, unlike other species in which fat and amino acids stimulate CCK release, ingested protein is the major stimulant of CCK secretion (1 1) .
CCK secretion in the rat is under negative feedback regulation by pancreatic secretion, whereby active proteases in the intestinal lumen inhibit CCK secretion; inactivation of intestinal proteases or binding of proteases by substrates such as protein or trypsin inhibitor results in stimulation of CCK secretion ( 12) . We have demonstrated previously that the ability ofprotein to stimulate CCK release in the rat is proportional to its ability to serve as a substrate for trypsin (1 1) . In light of these recent observations, we have developed a model in which rats are completely nourished by an elemental diet that does not stimulate CCK release. By adding small amounts of soybean trypsin inhibitor to the diet, we were then able to stimulate CCK secretion physiologically without significantly altering the nutritional status of the animals.
The intracellular mechanisms regulating CCK synthesis have not been examined previously. In particular, the factors regulating gastrointestinal hormone gene expression have not been studied. With the recent cloning of a cDNA for rat CCK (13), however, it is now possible to study the regulation of CCK mRNA levels and gene transcription. By stimulating CCK secretion with trypsin inhibitor, we examined the relationship of CCK secretion to intestinal CCK gene expression.
Methods
Surgical preparation of rats. Male Sprague-Dawley rats weighing 330-350 g were prepared with indwelling intraduodenal and intraperitoneal cannulae as previously described (14) . While the rats were under pentobarbital anesthesia, through a midline intraabdominal incision, a 0.9-mm silastic catheter was sewn into the proximal duodenum, 2 mm distal to the pylorus. A second cannula was sewn along the anterior abdominal wall for the intraperitoneal administration of antibiotic after surgery. Both cannulae were tunneled subcutaneously, exiting from an incision on the back. Rats were maintained in modified Bollman cages for a total period of 4 d ( 14) . For (9, 10) . Validation of this assay, which is based on the ability of CCK to stimulate amylase release from isolated rat pancreatic acini, has been previously described (9, 10) .
Preparation ofRNA from intestine. Within 1 min of killing, either the proximal 15 cm of small intestine, initiating at the pylorus, or a 15-cm segment of distal small intestine (extending 15 cm proximally from the colon) was removed and the luminal contents rinsed with 20 ml iced PBS. The intestine was then incised and the mucosa scraped off and immediately placed into guanidinium isothiocyante and homogenized with a Dounce homogenizer (Kontes Glass Co., Vineland, NJ). Total RNA was prepared by the guanidinium-cesium chloride method of Chirgwin et al. (15) . RNA concentrations were estimated using absorbance at 260 nm (1.0 OD = 40 Mg).
Slot blots and Northern transfers. Poly (A)' RNA was obtained by oligo (dt) cellulose chromatography (16) . For Northern transfers, poly (A)' RNA was denatured in formaldehyde, subjected to electrophoresis in 1% agarose, and transferred to nitrocellulose paper (17) . For slot blots RNA was denatured as described by Thomas (18) , and various dilutions of RNA were immobilized to nitrocellulose using a slot blot apparatus (Schleicher & Schuell, Inc., Keene, NH).
cDNA labeling and hybridization offilters. These studies used a full-length CCK cDNA probe containing 33 nucleotides in the 5'-noncoding region, the complete coding region, and 199 nucleotides in the 3'-noncoding region (13) . This cDNA cloned into the plasmid pBR322 was kindly provided by Dr. Jack Dixon (Purdue University, West Lafayette, IN) ( 13). A cDNA probe for ,B-actin also cloned into pBR322 (19) was used as a control. These cDNA probes were nicktranslated (labeling kit; Bethesda Research Laboratories, Gaithersburg, MD) to specific activities of 1 X 109 cpm/Mg. Filters containing RNA were prehybridized and hybridized with 1 X I07 cpm/ml CCK cDNA or fl-actin cDNA and washed as described (17) . Filters were exposed to Kodak XAR-5 film in the presence of two intensifying screens at -70°C for 8 h for ,B-actin and 24 h for CCK.
Isolation ofnuclei and run-on assays. Nuclei were prepared from 1 X 108 cells of intestinal epithelium by washing twice in buffered saline followed by resuspension in lysis buffer containing 10 mM Tris (pH 7.4), 10 mM NaCl, 5 mM MgCl2, and 0.5% NP-40 (20 (Fig. 2) . With the CCK cDNA probe autoradiographs of these transfers displayed a single band of -750 bp. With the fl-actin probe, a single band of -2,000 bp was seen. These electrophoretic patterns are consistent with previously reported mRNA sizes for these proteins (12, 18) . The relative abundance of actin mRNA was comparable in both the proximal and distal intestine. CCK mRNA was 460±70% (mean+SEM, n = 3) more abundant, however, in the proximal small intestine. This finding is consistent with the greater concentration of CCK and CCK-producing endocrine cells in the proximal intestine as compared with the distal small intestine (23) .
To determine the relationship between CCK secretion and CCK mRNA levels, intestine from the same animals in which CCK was measured was harvested for preparation of RNA. At Time (hours) Figure 1 . the times indicated, total RNA was prepared from the proximal intestine, slotted onto nitrocellulose, and hybridized with labeled cDNA probes (Fig. 3) . The relative abundance of,Bactin RNA did not change with trypsin inhibitor feeding. CCK RNA levels increased 330±50% (n = 4), however, within 12 h and 400±80% after 24 h of treatment. Run-on assays. To determine whether the observed changes in CCK RNA levels that occurred with trypsin inhibitor treatment were transcriptional, nuclear run-on assays were performed. In nuclear run-on transcription assays, transcripts that are initiated in the whole cell are elongated in isolated nuclei and reflect the ongoing rate of transcription (24) . To examine the transcription system, 5 4 g of CCK cDNA plasmid, pBR322 (the cloning vector used for CCK), and f,-actin cDNA plasmids were immobilized on nitrocellulose and hybridized with the nuclear transcription run-on products (Fig.  4) . Nuclei from trypsin inhibitor-treated intestine at 4 h increased the CCK hybridization signal 300±40% (n = 4) over the corresponding unstimulated control signal. In comparison, the ,B-actin signal remained unchanged, and no significant signal was seen with pBR322. Transcription signals remained elevated relative to fl-actin at 12 and 24 h of trypsin inhibitor treatment. The addition of 2 ug/ml a-amanitin to the nuclear incubation (a concentration that preferentially inhibits RNA polymerase II [24] ), markedly reduced the signal obtained. This finding indicated that the CCK transcription signal was produced by RNA polymerase II, and therefore, was either mRNA or its precursor. 
Discussion
In the current study, we have utilized an in vivo rat model for stimulating CCK secretion in an effort to study the regulation of intestinal CCK gene expression. Previously we and others have shown that CCK secretion is stimulated by either the presence ofintact protein ( 11) or the inhibition ofintraluminal trypsin activity (12) . In the current study, we introduced trypsin inhibitor via an indwelling intraduodenal cannula and demonstrated that high plasma CCK levels are associated with increased intestinal CCK mRNA levels. This dietary influence on CCK mRNA levels was specific as no parallel change in ,B-actin mRNA levels could be detected.
The relationship between stimulation of hormone secretion and hormone synthesis has not been previously documented for any gastrointestinal hormone. In other endocrine systems the relationship between stimulation of hormone secretion and hormone synthesis has been confusing. Growth hormone (GH)' mRNA levels have been demonstrated to be regulated by thyroid and glucocorticoid hormones (25). These elevators of GH mRNA levels, however, have no effect on GH secretion (25). In contrast, studies have revealed that stimulation of GH secretion by growth hormone releasing factor is independent ofGH gene transcription (26) . The The observed increase in CCK mRNA levels could result from two possible mechanisms. One possibility is that stabilization of existing mRNA occurs such that CCK mRNA is not degraded as rapidly, i.e., it has a longer t/2. A second possibility is that trypsin inhibitor stimulation of CCK secretion influenced CCK gene transcription. Because CCK is not an abundant gene product in intestinal mucosa, we used a highly sensitive run-on method previously developed to measure low abundant oncogenes (20) .
Nuclear run-on assays indicated that increased CCK mRNA levels were accompanied by increases in CCK gene transcription. This effect was specific, as no increase in fl-actin gene transcription was observed. We consider that the transcription assay displayed a high degree offidelity since nonspecific hybridization as measured by hybridization to the pBR322 control plasmid was undetectable. In addition, the inclusion of a-amanitin eliminated both fl-actin and CCK transcription signals. These data indicate that the increase in CCK mRNA is secondary to an increase in the transcription of the CCK gene. These observations provide the first evidence for transcriptional regulation of an intestinal polypeptide hor- 
